Correlation Between Design Therapeutics and VeriSign

Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and VeriSign at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and VeriSign into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Design Therapeutics and VeriSign, you can compare the effects of market volatilities on Design Therapeutics and VeriSign and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of VeriSign. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and VeriSign.

Diversification Opportunities for Design Therapeutics and VeriSign

-0.05

Correlation Coefficient

Design Therapeutics  VeriSign

Good diversification

The 3 months correlation between Design and VeriSign is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and VeriSign in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VeriSign and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with VeriSign. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VeriSign has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and VeriSign go up and down completely randomly.

Pair Corralation between Design Therapeutics and VeriSign

Given the investment horizon of 90 days Design Therapeutics is expected to generate 2.31 times less return on investment than VeriSign. In addition to that, Design Therapeutics is 4.04 times more volatile than VeriSign. It trades about 0.02 of its total potential returns per unit of risk. VeriSign is currently generating about 0.15 per unit of volatility. If you would invest  18,512  in VeriSign on October 24, 2024 and sell it today you would earn a total of  2,530  from holding VeriSign or generate 13.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Design Therapeutics  vs.  VeriSign

Design Therapeutics

Risk-Adjusted Performance

1 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Design Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy technical and fundamental indicators, Design Therapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

VeriSign

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in VeriSign are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, VeriSign displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Design Therapeutics and VeriSign

The main advantage of trading using opposite Design Therapeutics and VeriSign positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, VeriSign can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VeriSign will offset losses from the drop in VeriSign's long position.

The idea behind Design Therapeutics and VeriSign pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.